PUBLISHER: Grand View Research | PRODUCT CODE: 2152360
PUBLISHER: Grand View Research | PRODUCT CODE: 2152360
The global AI-assisted radiation therapy planning software market size was valued at USD 659.6 million in 2025 and is projected to grow from USD 743.5 million in 2026 to USD 1,815.3 million by 2033, at a CAGR of 13.6% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.4% in 2025. Growth is driven by the rising prevalence of cancer, the increased demand for precise, personalized radiation therapy, and the broader adoption of artificial intelligence in radiation oncology. AI-assisted software automates treatment planning, contouring, dose optimization, and quality assurance, which improves workflow efficiency and treatment consistency. The expanded use of adaptive radiotherapy, combined with the need to reduce planning time and address anatomical changes during treatment, is also expected to accelerate market growth.
Global AI-assisted Radiation Therapy Planning Software Market Report Segmentation
This report forecasts revenue growth at the global, regional, & country levels and provides an analysis of industry trends in each sub segment from 2021 to 2033. For this study, Grand View Research has segmented the global AI-assisted radiation therapy planning software market report on the basis of deployment mode, component, end use, and region: